This is pretty cool stuff. Amazing to think what they can do in regards to selection 20 or 50 or 100 years from now.
MicroSort® Clinical Trial Reaches Birth Limit
Effort Now Focused on FDA Approval
The MicroSort® Division of GIVF has now reached an important milestone in our effort to have MicroSort® approved by the FDA and made more widely available. The maximum number of MicroSort procedures that are allowed under the protocol has been reached, and we have requested that the FDA grant us permission to provide continued access to the MicroSort® technology. If permission to proceed is granted by the FDA, this step would not represent FDA approval, but would allow us to operate under the same rules as the clinical trial.
We will provide more information on this web page as we work through the necessary procedures and as we receive feedback from the FDA with regards to our request for continued access. If you wish to be notified of any changes in the status of MicroSort® procedures, we invite you to sign up for MicroSort® eNews by clicking here. Any news and/or updates about MicroSort will be sent via email to those signed up for MicroSort® eNews.
MicroSort® General Information
The Genetics & IVF Institute is offering couples the ability to increase the chance of having a child of the desired gender to reduce the probability of X-linked diseases or for family balancing. Utilizing new flow cytometric separation technology, the X (female) or Y (male) chromosome-bearing sperm can be sorted and the enriched fraction of sorted sperm used to achieve pregnancy.
Semen specimens contain approximately 50% X- and 50% Y-bearing sperm. If the proportion of either X- or Y-bearing sperm is increased, the chance of having a child with the desired sex should be correspondingly increased. MicroSort technology currently provides an average increase in X-bearing sperm to 88% (determined by DNA analysis) in the enriched X-sorted sample (XSort®). The content of Y-bearing sperm is increased to an average of 73% (determined by DNA analysis) in enriched Y-sorted samples (YSort®). The current technology does not result in the complete exclusion of either X- or Y-bearing sperm from the final sperm preparation. DNA analysis by fluorescence in situ hybridization (FISH) can be performed on a portion of the sorted sample to indicate its percentages of the different sperm cells.
http://www.microsort.net/